BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modica C, Gallo S, Chiriaco C, Spilinga M, Comoglio PM, Crepaldi T, Basilico C, Vigna E. Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody. Cancers (Basel) 2020;12:E741. [PMID: 32245152 DOI: 10.3390/cancers12030741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Modica C, Basilico C, Chiriaco C, Borrelli N, Comoglio PM, Vigna E. A receptor-antibody hybrid hampering MET-driven metastatic spread. J Exp Clin Cancer Res 2021;40:32. [PMID: 33446252 DOI: 10.1186/s13046-020-01822-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Park KC, Richardson DR. The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents. Biochim Biophys Acta Gen Subj 2020;1864:129650. [PMID: 32522525 DOI: 10.1016/j.bbagen.2020.129650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]